GSFPX
Price
$18.22
Change
-$0.04 (-0.22%)
Updated
Sep 5 closing price
Net Assets
3.63B
HROAX
Price
$13.45
Change
+$0.04 (+0.30%)
Updated
Sep 5 closing price
Net Assets
36.11M
Interact to see
Advertisement

GSFPX vs HROAX

Header iconGSFPX vs HROAX Comparison
Open Charts GSFPX vs HROAXBanner chart's image
Goldman Sachs US Eq Div and Premium P
Price$18.22
Change-$0.04 (-0.22%)
VolumeN/A
Net Assets3.63B
M3Sixty Income and Opportunity A
Price$13.45
Change+$0.04 (+0.30%)
VolumeN/A
Net Assets36.11M
GSFPX vs HROAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSFPX vs. HROAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSFPX is a Buy and HROAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSFPX has more cash in the bank: 3.63B vs. HROAX (36.1M). GSFPX pays higher dividends than HROAX: GSFPX (1.15) vs HROAX (0.00). GSFPX was incepted earlier than HROAX: GSFPX (7 years) vs HROAX (10 years). HROAX (3.01) is less costly to investors than GSFPX (0.74). HROAX is a more actively managed with annual turnover of: 487.35 vs. GSFPX (23.00). GSFPX has a lower initial minimum investment than HROAX: GSFPX (0) vs HROAX (1000). HROAX annual gain was more profitable for investors over the last year : 19.03 vs. GSFPX (9.66). GSFPX return over 5 years is better than : 41.29 vs. HROAX (25.23).
GSFPXHROAXGSFPX / HROAX
Total Expense Ratio0.682.4628%
Annual Report Gross Expense Ratio0.743.0125%
Fund Existence7 years10 years-
Gain YTD7.93412.83662%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.63B36.1M10,064%
Annual Yield % from dividends1.150.00-
Returns for 1 year9.6619.0351%
Returns for 3 years36.7644.0084%
Returns for 5 years41.2925.23164%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACWZX19.340.15
+0.78%
AMG GW&K Small/Mid Cap Growth Z
TGCNX25.550.01
+0.04%
TCW Concentrated Large Cap Growth N Cl
TNBRX20.51-0.04
-0.17%
1290 SmartBeta Equity R
LAVYX16.81-0.05
-0.30%
Lord Abbett Fundamental Equity I
JVAQX40.54-0.13
-0.32%
JPMorgan Value Advantage R4